Palmoplantar pustulosis with arthro-osteitis: successful treatment with etanercept and acitretin.
Antoniou
C
C
Nicolaidou
E
E
Moustou
A E
AE
Stratigos
A
A
Katsambas
A
A
D017255:Acitretin / Q000008:administration & dosage / Q000627:therapeutic use*; D000328:Adult; D001168:Arthritis / Q000150:complications / Q000188:drug therapy*; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D007641:Keratolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D010000:Osteitis / Q000150:complications / Q000188:drug therapy*; D011565:Psoriasis / Q000150:complications / Q000188:drug therapy*; D018124:Receptors, Tumor Necrosis Factor / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D007641:Keratolytic Agents; D018124:Receptors, Tumor Necrosis Factor; D017255:Acitretin; D000068800:Etanercept